A Message from the ESMO President By Ogkologos - March 17, 2020 625 0 Facebook Twitter Google+ Pinterest WhatsApp Source RELATED ARTICLESMORE FROM AUTHOR ESMO Announces 2026 Society Award Recipients Honouring Excellence in Cancer Research, Care and Leadership Adjuvant Olaparib Continues to Improve Multiple Outcomes in Patients with Germline BRCA1/2-associated High-Risk HER2-negative EBC EMA Recommends Refusing the Marketing Authorisation for Copper (64Cu) Oxodotreotide MOST POPULAR Worried Cancer Patients Face Delayed Treatment Because Of Pandemic April 1, 2020 November is National Family Caregivers Month November 24, 2020 Why the Bone Marrow Registry Needs More Diverse Donors and How... March 30, 2021 ESMO Calls for Cancer Care Integration in EU Global Health Resilience... March 24, 2026 Load more HOT NEWS Neoadjuvant Histotype-Tailored Treatment with Trabectedin Not Inferior to Standard Chemotherapy with... FDA Grants Accelerated Approval to Asciminib for Newly Diagnosed Chronic Myeloid... FDA Approves Nivolumab in Combination with Cisplatin and Gemcitabine for Unresectable... Empoderar a las personas con cáncer: preguntas y respuestas con la...
